Vontobel Holding
VIR icon

Vontobel Holding’s Vir Biotechnology VIR Stock Holding History

Vontobel Holding’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
36,815
+3,767
+11% +$35.8K ﹤0.01% 1162
2026
Q1 		$296K Buy
+33,048
New +$263K ﹤0.01% 1000
2025
Q3 		– Sell
-45,356
Closed -$229K – 1439
2025
Q2 		$229K Sell
45,356
-3,013
-6% -$16.2K ﹤0.01% 1131
2025
Q1 		$313K Sell
48,369
-6,872
-12% -$61.1K ﹤0.01% 900
2024
Q4 		$405K Sell
55,241
-2,205
-4% -$17.4K ﹤0.01% 843
2024
Q3 		$430K Buy
57,446
+12,511
+28% +$109K ﹤0.01% 824
2024
Q2 		$400K Sell
44,935
-1,974
-4% -$18.9K ﹤0.01% 836
2024
Q1 		$475K Sell
46,909
-690
-1% -$7.03K ﹤0.01% 797
2023
Q4 		$479K Sell
47,599
-3,220
-6% -$29.4K ﹤0.01% 809
2023
Q3 		$476K Buy
50,819
+24,656
+94% +$352K ﹤0.01% 786
2023
Q2 		$642K Sell
26,163
-2,087
-7% -$52.4K 0.01% 728
2023
Q1 		$657K Sell
28,250
-4,264
-13% -$109K 0.01% 714
2022
Q4 		$823K Sell
32,514
-6,066
-16% -$149K 0.01% 625
2022
Q3 		$744K Buy
38,580
+1,436
+4% +$36.5K 0.01% 612
2022
Q2 		$966K Sell
37,144
-6,391
-15% -$149K 0.01% 549
2022
Q1 		$1.13M Buy
43,535
+12,499
+40% +$371K 0.01% 582
2021
Q4 		$1.26M Sell
31,036
-1,250
-4% -$49K 0.01% 568
2021
Q3 		$1.41M Buy
32,286
+7,595
+31% +$329K 0.01% 535
2021
Q2 		$1.17M Sell
24,691
-1,715
-6% -$78K 0.01% 559
2021
Q1 		$1.35M Sell
26,406
-16,305
-38% -$879K 0.01% 477
2020
Q4 		$1.14M Buy
+42,711
New +$1.39M 0.01% 511

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vontobel Holding's VIR Position: Q2 2026 in Review

Vontobel Holding increased its Vir Biotechnology (VIR) stake by 11% in Q2 2026, buying an estimated $35.8K and bringing the position to 36,815 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Vontobel Holding first reported a position in VIR in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.41M in Q3 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Vontobel Holding held 36,815 shares of Vir Biotechnology worth $375K as of Q2 2026.
  • Vontobel Holding bought 3,767 Vir Biotechnology shares in Q2 2026, an estimated $35.8K.
  • Vir Biotechnology made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1162 holding.
  • Vontobel Holding first reported a position in Vir Biotechnology in Q4 2020 and has held it in 21 quarters since.
  • Vontobel Holding's Vir Biotechnology position peaked at $1.41M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.